Keyphrases
ELK3
100%
Natural Killer Cells
85%
Glioma
46%
Ell3
42%
Glioblastoma
42%
Low-intensity Pulsed Ultrasound (LIPUS)
37%
Breast Cancer Cells
31%
Triple-negative Breast Cancer Cells
30%
Lymphatic Endothelial Cells
30%
Cancer Immunotherapy
29%
Nanoparticles
28%
Doxorubicin
28%
GATA3
28%
Metastatic Breast Cancer
28%
Metastasis
26%
ERK2
23%
MDA-MB-231
18%
Cell Therapy
18%
Triple-negative Breast Cancer
18%
Microbubbles
18%
Lymphangiogenesis
17%
Phosphorylation
17%
Immune Checkpoint Blockade
17%
Magnetic Resonance Imaging
17%
PD-1 Blockade
17%
Programmed Death-ligand 1 (PD-L1)
17%
Genetic Engineering
16%
Peritumoral
16%
Recurrent Glioblastoma
16%
Overall Survival
16%
Cancer Cells
15%
E-cadherin
15%
Breast Cancer Cell Lines
15%
Antitumor Activity
14%
Immune Regulation
14%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
14%
5-fluorouracil Resistance
14%
Paclitaxel
14%
Antitumor Efficacy
14%
Carboplatin
14%
Cationic Nanoparticles
14%
Novel Functions
14%
Vascular Endothelial Growth factor-C (VEGF-C)
14%
Recent Advances
14%
Cell Adhesion
14%
Magnetic Nanocomplex
14%
Potential Therapeutics
14%
Therapeutic Use
14%
Mitochondrial Dynamics
14%
Prostate Cancer
14%
Medicine and Dentistry
Natural Killer Cell
57%
Metastatic Carcinoma
52%
Nanoparticle
42%
Cancer Cell
40%
Lymph Duct
35%
Endothelial Cell
32%
Breast Cancer
28%
In Vitro
21%
Neoplasm
21%
Triple Negative Breast Cancer
20%
Glioblastoma
20%
Magnetic Resonance Imaging
17%
Lymphangiogenesis
17%
Immune Checkpoint Blockade
17%
Ganglioglioma
17%
Immunotherapy
17%
Genetic Engineering
16%
Cancer Immunotherapy
15%
Solid Malignant Neoplasm
14%
Antineoplastic Activity
14%
Breast Cancer Cell Line
14%
Mitogen Activated Protein Kinase 3
14%
Transcription Factor GATA 3
14%
microRNA
14%
Prostate Cancer
14%
Overall Survival
14%
Fluorouracil
14%
Vasculotropin C
14%
CTLA-4
14%
Cancer Growth
14%
Ferroptosis
14%
Checkpoint Kinase 2
14%
Checkpoint Kinase 1
14%
Immune Response
14%
MCF-7
10%
Nivolumab
8%
Cytotoxic T-Cell
8%
Malignant Neoplasm
8%
Tumor Microenvironment
7%
Ferumoxytol
7%
Programmed Death-Ligand 1
7%
Tumor Progression
6%
Combination Therapy
5%
Meta-Analysis
5%
Biological Marker
5%
Vasculotropin Receptor 3
5%
Antigen Presentation
5%
Kinase
5%
Clinical Trial
5%
Cell Therapy
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
91%
Natural Killer Cell
57%
GATA3
28%
P53
22%
Genetics
18%
Programmed Cell Death
17%
Magnetic Resonance Imaging
17%
Genetic Engineering
16%
Blood Brain Barrier
16%
Cadherin
15%
Cancer Immunotherapy
15%
Lymphangiogenesis
14%
Multigene Family
14%
Fluorouracil
14%
Cell Adhesion
14%
Mitochondrial Dynamics
14%
Solution and Solubility
14%
Vascular Endothelial Growth Factor
14%
ZEB1
14%
Stem Cell
14%
Biochemistry
14%
Doxorubicin
14%
CTLA-4
14%
Ubiquitin
14%
Immune Response
14%
Kinase
14%
Phosphotransferase
14%
Immune Checkpoints
14%
Tumor Progression
11%
T Cell
11%
Microbubble
8%
Cytokine
8%
CD8
7%
Tumor-Associated Macrophage
7%
Microglia
7%
Transcriptional Activator
6%
Carcinogenesis
6%
Mesenchymal-Epithelial Transition
6%
Mitochondrial Fission
6%
Plant Genome
5%
Wnt Signaling Pathway
5%
Gene Expression
5%
Regulatory T Cell
5%